Not a good deal!11 Dec 2023 15:14
I think they have only them selves to blame, so myself for not thinking through the consequences, for not having done flow tests!
Not having done these test they have left open question marks regarding how quick , and capex we need for a substantial flow rate!
Hence the price of the extra 10% is relative high compared to the first 45%.
Unfortunately I was not available for the question time but having listened to it, it seems there was no question raised regarding the 37.5% give away for the further resanna license and how this will be funded and in the future!
Do we need several years of cash flow first to be able to support this project.
Ap mentioned something about giving money back to the shareholders but looking at his history of timelines that doesn’t bode well!
Ask if there was an offer made for the whole company, he said yes, unfortunately there was no indication of a valuation (share price!). The offer would also not been a real offer since that would have been subject to rns…..
Still holding and hoping that the onshore drills come in and we get an income stream since the money we get from the deal is really not that great, that will have run out before 2026……
After that, I believe the news of the flow rates and then the FID will be the catalyst for the share price.
For now, hopefully it steadies ……
2024 is the new 2023 for Chars timeline keeping and promising…..